ATGAM Side Effects

7018802-4 | Blood Lactate Dehydrogenase Increased, Dysstasia, Gait Disturbance, Hyperaesthesia, Neuralgia, Pain In Extremity, Platelet Count Decreased, Post Transplant Distal Limb Syndrome, Serum Sickness
on Sep 22, 2010 Female patient from UNITED STATES , weighting 176.4 lb, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, dysstasia, gait disturbance, hyperaesthesia, neuralgia, pain in extremity, platelet count decreased, post transplant distal limb syndrome, serum sickness. Atgam dosage: 3200 Mg Daily. During the same period patient was treated with SOLIRIS (900mg Every 14 Days) (View Soliris Review and Soliris Label ), CYCLOSPORINE (200mg Twice Daily) (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), SOLU MEDROL (60mg, 2x/day, For 8 Dose) (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

6939173-5 | Aplastic Anaemia, Chills, Liver Function Test Abnormal, Rash, Viral Infection
Patient was taking Atgam (View Usage). Patient had the following side effects: aplastic anaemia, chills, liver function test abnormal, rash (What is rash?), viral infection (What is viral infection?) on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 212.5 lb, was diagnosed with aplastic anaemia, prophylaxis and. Atgam dosage: Unk. During the same period patient was treated with PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6895384-9 | Aplastic Anaemia, Chills, Liver Function Test Abnormal, Rash, Viral Infection
Adverse event was reported on Jul 23, 2010 by a Male patient taking Atgam (View Usage) (Dosage: Unk) was diagnosed with aplastic anaemia, prophylaxis and. Location: UNITED STATES , weighting 212.5 lb, After Atgam was administered, patient had the following side effects: aplastic anaemia, chills, liver function test abnormal, rash (What is rash?), viral infection (What is viral infection?). During the same period patient was treated with PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6682435-X | Chills, Haemoglobin Decreased, Malaise, Pyrexia
on Apr 08, 2010 Male patient from UNITED STATES , 80 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: chills, haemoglobin decreased, malaise, pyrexia. Atgam dosage: 40 Mg/kg, Unk. During the same period patient was treated with CYCLOSPORINE (250 Mg, 2x/day) (View Cyclosporine Review and Cyclosporine Label ), FUROSEMIDE (20 Mg, 2x/day) (View Furosemide Review and Furosemide Label ).


6540116-7 | Chest Pain, Chills, Electrocardiogram St Segment Depression, Pyrexia, Troponin Increased
on Jan 05, 2010 Female patient from UNITED STATES , 62 years of age, weighting 158.7 lb, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient had the following side effects: chest pain (What is chest pain?), chills, electrocardiogram st segment depression, pyrexia, troponin increased. Atgam dosage: . During the same period patient was treated with TYLENOL (CAPLET) (Unk) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), ZOVIRAX (800 Mg, 2x/day) (View Zovirax Review and Zovirax Label ), CYCLOSPORINE (75 Mg, 2x/day) (View Cyclosporine Review and Cyclosporine Label ), POSACONAZOLE (200 Mg, 3x/day) (View Posaconazole Review and Posaconazole Label ), NEUPOGEN (Unk) (View Neupogen Review and Neupogen Label ), LEVAQUIN (500 Mg, 2x/day) (View Levaquin Review and Levaquin Label ), DEMEROL (Unk) (View Demerol Review and Demerol Label ).

6539323-9 | Hepatotoxicity
Patient was taking Atgam (View Usage). After Atgam was administered, patient had the following side effects: hepatotoxicity on Sep 30, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 125.0 lb, was diagnosed with aplastic anaemia and. Atgam dosage: 2250 Mg, Intravenous. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), VALTREX (View Valtrex Review and Valtrex Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), CLARITIN (View Claritin Review and Claritin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6519339-9 | Blood Bilirubin Increased, Haemoglobin Decreased, Phlebitis, Platelet Count Decreased, Renal Function Test Abnormal, White Blood Cell Count Decreased
Adverse event was reported on Dec 14, 2009 by a Male patient taking Atgam (View Usage) (Dosage: 20 Mg/kg, 1x/day) was diagnosed with aplastic anaemia and. Location: UNITED STATES , 63 years of age, weighting 253.5 lb, Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, haemoglobin decreased, phlebitis, platelet count decreased, renal function test abnormal, white blood cell count decreased.

6474194-0 | Blood Bilirubin Increased, Haemoglobin Decreased, Phlebitis, Platelet Count Decreased, Renal Function Test Abnormal, White Blood Cell Count Decreased
on Nov 27, 2009 Male patient from UNITED STATES , 63 years of age, weighting 253.5 lb, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient had the following side effects: blood bilirubin increased, haemoglobin decreased, phlebitis, platelet count decreased, renal function test abnormal, white blood cell count decreased. Atgam dosage: 20 Mg/kg, 1x/day.

6472223-1 | Hypoxia, Lung Infiltration
on Nov 23, 2009 Male patient from CANADA , 33 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). After Atgam was administered, patient had the following side effects: hypoxia, lung infiltration. Atgam dosage: 40 Mg/kg, 1x/day. During the same period patient was treated with HYDROCORTISONE (100 Mg, Unk) (View Hydrocortisone Review and Hydrocortisone Label ), DIPHENHYDRAMINE (50 Mg, Unk) (View Diphenhydramine Review and Diphenhydramine Label ).

6439050-2 | Blood Bilirubin Increased, Haemoglobin Decreased, Phlebitis, Platelet Count Decreased, Renal Function Test Abnormal, White Blood Cell Count Decreased
Patient was taking Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, haemoglobin decreased, phlebitis, platelet count decreased, renal function test abnormal, white blood cell count decreased on Nov 09, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 253.5 lb, was diagnosed with aplastic anaemia and. Atgam dosage: 20 Mg/kg, 1x/day.

6437530-7 | Cd4 Lymphocytes Increased, Cd8 Lymphocytes Increased
Adverse event was reported on Nov 05, 2009 by a Male patient taking Atgam (View Usage) (Dosage: 1000 Mg, 1x/day) was diagnosed with heart transplant (What is heart transplant?) and. Location: UNITED STATES , weighting 149.9 lb, Patient had the following side effects: cd4 lymphocytes increased, cd8 lymphocytes increased. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE SODIUM (View Mycophenolate Sodium Review and Mycophenolate Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), STEROID ANTIBACTERIALS (View Steroid Antibacterials Review and Steroid Antibacterials Label ).

6437406-5 | Cd4 Lymphocytes Increased, Cd8 Lymphocytes Increased
on Nov 05, 2009 Male patient from UNITED STATES , weighting 149.9 lb, was diagnosed with heart transplant (What is heart transplant?) and was treated with Atgam (View Usage). After Atgam was administered, patient had the following side effects: cd4 lymphocytes increased, cd8 lymphocytes increased. Atgam dosage: 1250 Mg, 1x/day. During the same period patient was treated with TUMS (View Tums Review and Tums Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PEPCID (View Pepcid Review and Pepcid Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), SENNA (View Senna Review and Senna Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

6428705-1 |
on May 09, 2008 Female patient from UNITED STATES , 67 years of age, weighting 147.7 lb, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). . Atgam dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ESTROGENS CONJUGATED (View Estrogens Conjugated Review and Estrogens Conjugated Label ).

6298239-6 | Convulsion, Muscular Weakness
Patient was taking Atgam (View Usage). Patient had the following side effects: convulsion, muscular weakness on Aug 05, 2009 from INDIA Additional patient health information: Female patient , child 8 years of age, was diagnosed with aplastic anaemia and. Atgam dosage: 150 Mg/kg, 1x/day.

6275534-8 | Aplastic Anaemia
Adverse event was reported on Jul 21, 2009 by a Female patient taking Atgam (View Usage) (Dosage: 750 Mg For 10 Days) was diagnosed with aplastic anaemia and. Location: UNITED STATES , 71 years of age, weighting 110.0 lb, After Atgam was administered, patient had the following side effects: aplastic anaemia. Patient was hospitalized.

6253622-X | Convulsion, Muscular Weakness
on Jun 24, 2009 Female patient from INDIA , child 8 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, muscular weakness. Atgam dosage: 150 Mg/kg, 1x/day.

6217103-1 | Aplastic Anaemia
on May 22, 2009 Female patient from UNITED STATES , 71 years of age, weighting 110.0 lb, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient had the following side effects: aplastic anaemia. Atgam dosage: 750 Mg For 10 Days. Patient was hospitalized.

6025160-0 | Cd4 Lymphocytes Increased, Cd8 Lymphocytes Increased
Patient was taking Atgam (View Usage). After Atgam was administered, patient had the following side effects: cd4 lymphocytes increased, cd8 lymphocytes increased on Dec 31, 2008 from UNITED STATES Additional patient health information: Male patient , 23 years of age, weighting 149.9 lb, . Atgam dosage: . During the same period patient was treated with TUMS (View Tums Review and Tums Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PEPCID (View Pepcid Review and Pepcid Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), SENNA (View Senna Review and Senna Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

5960788-5 | Cytomegalovirus Infection, Disease Progression, Epstein-barr Virus Infection
Adverse event was reported on Nov 10, 2008 by a Female patient taking Atgam (View Usage) (Dosage: ) . Location: UNITED KINGDOM , child 7 years of age, Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), disease progression, epstein-barr virus infection. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TREOSULFAN (View Treosulfan Review and Treosulfan Label ).

5945639-7 | Cd4 Lymphocytes Increased, Cd8 Lymphocytes Increased
on Oct 28, 2008 Male patient from UNITED STATES , 23 years of age, weighting 149.9 lb, was treated with Atgam (View Usage). Patient had the following side effects: cd4 lymphocytes increased, cd8 lymphocytes increased. Atgam dosage: . During the same period patient was treated with TUMS (View Tums Review and Tums Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PEPCID (View Pepcid Review and Pepcid Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), SENNA (View Senna Review and Senna Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

5616687-1 | Agitation, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Cardiogenic Shock, Chest X-ray Abnormal, Hypotension, Hypoxia
on Jan 31, 2008 Male patient from AUSTRALIA , 60 years of age, was diagnosed with renal transplant and was treated with Atgam (View Usage). After Atgam was administered, patient had the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, cardiogenic shock, chest x-ray abnormal, hypotension, hypoxia. Atgam dosage: 8 Doses. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5423710-6 | Lymphoproliferative Disorder
Patient was taking Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoproliferative disorder on Jan 27, 2006 from AUSTRIA Additional patient health information: Male patient , 27 years of age, was diagnosed with heart transplant (What is heart transplant?) and. Atgam dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

5245597-7 | Hypersensitivity, Loss Of Consciousness, Rash, Tremor
Adverse event was reported on Feb 12, 2007 by a Female patient taking Atgam (View Usage) (Dosage: ) was diagnosed with aplastic anaemia, prophylaxis and. Location: CANADA , 40 years of age, Patient had the following side effects: hypersensitivity, loss of consciousness, rash (What is rash?), tremor. During the same period patient was treated with DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

4960434-3 | Epstein-barr Virus Antibody Positive, Epstein-barr Virus Infection, Lymphoproliferative Disorder, Malignant Neoplasm Progression, Viral Load Increased
on Mar 21, 2006 Male patient from TURKEY , 23 years of age, was diagnosed with stem cell transplant and was treated with Atgam (View Usage). After Atgam was administered, patient had the following side effects: epstein-barr virus antibody positive, epstein-barr virus infection, lymphoproliferative disorder, malignant neoplasm progression, viral load increased. Atgam dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), IRRADIATION (View Irradiation Review and Irradiation Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

4940511-3 | Rash Erythematous
on Sep 13, 2005 Male patient from UNITED STATES , 80 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: rash erythematous. Atgam dosage: 3000 Mg (40 Mg/kg). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PREVACID (View Prevacid Review and Prevacid Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

4940510-1 | Bacterial Culture Positive, Cardiac Failure Congestive
Patient was taking Atgam (View Usage). Patient had the following side effects: bacterial culture positive, cardiac failure congestive on Apr 28, 2005 from UNITED STATES Additional patient health information: Female patient , 18 years of age, weighting 127.9 lb, was diagnosed with immunosuppression and. Atgam dosage: 10 Mg/kg (10 Mg/kg, 2 Doses), Intravenous. During the same period patient was treated with IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), CONLUNETT (MESTRANOL, NORETHISTERONE) (View Conlunett (mestranol, Norethisterone) Review and Conlunett (mestranol, Norethisterone) Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ). Patient was hospitalized.

4891973-1 | Dyspnoea, Hypotension, Infusion Related Reaction, Urticaria
Adverse event was reported on Jan 24, 2006 by a Male patient taking Atgam (View Usage) (Dosage: 400 Mg Iv Daily) was diagnosed with lung transplant rejection and. Location: UNITED STATES , weighting 167.6 lb, After Atgam was administered, patient had the following side effects: dyspnoea, hypotension, infusion related reaction, urticaria. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CALATONIN (View Calatonin Review and Calatonin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), INSULIN (View Insulin Review and Insulin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

4828438-9 | Bronchospasm, Chest Discomfort, Cough, Diarrhoea, Hypotension, Irritability, Loss Of Consciousness, Peripheral Circulatory Failure, Pulse Absent
on Oct 27, 2005 Female patient from INDIA , child 9 years of age, weighting 57.32 lb, was diagnosed with bone marrow transplant (What is bone marrow transplant?) and was treated with Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, chest discomfort, cough, diarrhoea, hypotension, irritability, loss of consciousness, peripheral circulatory failure, pulse absent. Atgam dosage: 500 Mg (1 In 1 D), Intravenous.

4828436-5 | Bronchospasm, Cough, Cyanosis, Diarrhoea, Dyspnoea, Hypotension, Oxygen Saturation Decreased, Rash
on Oct 27, 2005 Male patient from INDIA , child 7 years of age, weighting 41.89 lb, was diagnosed with bone marrow transplant (What is bone marrow transplant?), thalassaemia and was treated with Atgam (View Usage). Patient had the following side effects: bronchospasm, cough, cyanosis, diarrhoea, dyspnoea, hypotension, oxygen saturation decreased, rash (What is rash?). Atgam dosage: 1000 Mg, Intravenous.

4791773-7 | Blood Pressure Decreased, Cough, Cyanosis, Diarrhoea, Dyspnoea, Heart Rate Increased, Rash
Patient was taking Atgam (View Usage). After Atgam was administered, patient had the following side effects: blood pressure decreased, cough, cyanosis, diarrhoea, dyspnoea, heart rate increased, rash (What is rash?) on Sep 21, 2005 from INDIA Additional patient health information: Male patient , child 7 years of age, weighting 41.89 lb, was diagnosed with thalassaemia and. Atgam dosage: 750 Mg, Od, Intravenous.

4791772-5 | Blood Pressure Immeasurable, Bronchospasm, Chest Discomfort, Cough, Depressed Level Of Consciousness, Diarrhoea, Heart Rate Increased, Irritability, Loss Of Consciousness
Adverse event was reported on Sep 21, 2005 by a Female patient taking Atgam (View Usage) (Dosage: 750 Milligram (750 Mg, 1 In 1 D), Intravenous) was diagnosed with bone marrow transplant (What is bone marrow transplant?) and. Location: INDIA , child 9 years of age, weighting 57.32 lb, Patient experienced the following unwanted or unexpected effects: blood pressure immeasurable, bronchospasm, chest discomfort, cough, depressed level of consciousness, diarrhoea, heart rate increased, irritability, loss of consciousness.

4749788-0 | Congestive Cardiomyopathy
on Aug 16, 2005 Female patient from AUSTRALIA , 55 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient had the following side effects: congestive cardiomyopathy. Atgam dosage: . During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ).

4713493-7 | Activated Partial Thromboplastin Time Prolonged, Alanine Aminotransferase Increased, Atrioventricular Block Second Degree, Hyperbilirubinaemia, Hypersensitivity, Hypocalcaemia, Hypomagnesaemia, Infusion Related Reaction, International Normalised Ratio Increased
on Jun 21, 2005 Male patient from UNITED STATES , 50 years of age, weighting 263.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Atgam (View Usage). After Atgam was administered, patient had the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, atrioventricular block second degree, hyperbilirubinaemia, hypersensitivity, hypocalcaemia, hypomagnesaemia, infusion related reaction, international normalised ratio increased. Atgam dosage: 4820 Mg (qd), Intravenous. During the same period patient was treated with FLUDARABINE PHOSPHATE (47 Mg (qd), Intravenous) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), FUROSEMIDE (FUROSEMIDE) (View Furosemide (furosemide) Review and Furosemide (furosemide) Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ), TROGLITAZONE (TROGLITAZONE) (View Troglitazone (troglitazone) Review and Troglitazone (troglitazone) Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

4708315-4 | Erythema, Skin Reaction, Urticaria
Patient was taking Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, skin reaction, urticaria on Jun 08, 2005 from Additional patient health information: Male patient , 44 years of age, weighting 215.0 lb, was diagnosed with aplastic anaemia and. Atgam dosage: Intradermal. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ZANTAC (View Zantac Review and Zantac Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ELAVIL (View Elavil Review and Elavil Label ).

4690713-9 | Liver Function Test Abnormal, Pyrexia, Serum Sickness, Tachycardia
Adverse event was reported on Jun 14, 2005 by a Male patient taking Atgam (View Usage) (Dosage: 2800 Mg Daily Intravenous) was diagnosed with aplastic anaemia and. Location: , 53 years of age, Patient had the following side effects: liver function test abnormal, pyrexia, serum sickness, tachycardia. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE (View Thiamine Review and Thiamine Label ). Patient was hospitalized.

4690712-7 | Liver Function Test Abnormal, Pyrexia, Tachycardia
on Jun 14, 2005 Male patient from , 53 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). After Atgam was administered, patient had the following side effects: liver function test abnormal, pyrexia, tachycardia. Atgam dosage: 2800 Mg Daily Intravenous. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE (View Thiamine Review and Thiamine Label ). Patient was hospitalized.

4606491-5 | Aplasia Pure Red Cell, Urticaria
on May 06, 2004 Female patient from , 19 years of age, was diagnosed with aplastic anaemia and was treated with Atgam (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia pure red cell, urticaria. Atgam dosage: See Image. During the same period patient was treated with XX (View Xx Review and Xx Label ). Patient was hospitalized.